Anti-Diabetic
Glymark-M1
Glimepiride 1 mg + Metformin 500 mg (SR)
Sustained-release combination of Glimepiride and Metformin for improved glycemic control in Type 2 Diabetes.
10 x 10 TabletsKnow More
Anti-Diabetic
MARKVIL-M
Vildagliptin 50 mg + Metformin HCl 500 mg
MARKVIL-M combines Vildagliptin, a DPP-4 inhibitor, with Metformin Hydrochloride to enhance incretin-mediated insulin secretion and reduce hepatic glucose output — a modern approach to Type 2 Diabetes therapy.
- Pack
- 10 x 10 Tablets
- Category
- Anti-Diabetic
Indications / Common Uses
- Type 2 Diabetes Mellitus in adults
- Patients inadequately controlled on Metformin alone
- Combination therapy where DPP-4 inhibition is preferred
Benefits
- Low risk of hypoglycemia versus sulfonylureas
- Weight-neutral profile
- Improves both fasting and post-prandial glucose
Dosage Information
One tablet twice daily with meals, or as prescribed by a physician.
General information only. Follow your physician's prescription.
Storage
Store below 30°C. Protect from moisture and light.
Precautions
- Assess liver function before and during therapy
- Use with caution in renal impairment
- Discontinue temporarily during acute illness or dehydration
Medical Disclaimer
The information provided is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Always seek the guidance of a qualified physician regarding any medical condition or medication.
Related Products
Anti-Diabetic
Glymark-M2
Glimepiride 2 mg + Metformin 500 mg (SR)
Higher-strength sustained-release Glimepiride and Metformin combination for advanced Type 2 Diabetes management.
10 x 10 TabletsKnow More
Anti-Allergic
MARST-BL
Bilastine 20 mg + Montelukast 10 mg
A dual-action anti-allergic tablet combining Bilastine and Montelukast for effective relief from allergic rhinitis and related symptoms.
10 x 10 TabletsKnow More